159 related articles for article (PubMed ID: 28008934)
1. Driver gene classification reveals a substantial overrepresentation of tumor suppressors among very large chromatin-regulating proteins.
Waks Z; Weissbrod O; Carmeli B; Norel R; Utro F; Goldschmidt Y
Sci Rep; 2016 Dec; 6():38988. PubMed ID: 28008934
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
3. An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer.
Yang Z; Jones A; Widschwendter M; Teschendorff AE
Genome Biol; 2015 Jul; 16(1):140. PubMed ID: 26169266
[TBL] [Abstract][Full Text] [Related]
4. Interpreting pathways to discover cancer driver genes with Moonlight.
Colaprico A; Olsen C; Bailey MH; Odom GJ; Terkelsen T; Silva TC; Olsen AV; Cantini L; Zinovyev A; Barillot E; Noushmehr H; Bertoli G; Castiglioni I; Cava C; Bontempi G; Chen XS; Papaleo E
Nat Commun; 2020 Jan; 11(1):69. PubMed ID: 31900418
[TBL] [Abstract][Full Text] [Related]
5. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
6. Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.
Gonzalez-Perez A
Genome Med; 2016 Jan; 8(1):6. PubMed ID: 26792175
[TBL] [Abstract][Full Text] [Related]
7. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
8. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
9. Improving existing analysis pipeline to identify and analyze cancer driver genes using multi-omics data.
Nguyen QH; Le DH
Sci Rep; 2020 Nov; 10(1):20521. PubMed ID: 33239644
[TBL] [Abstract][Full Text] [Related]
10. Effects of Multi-Omics Characteristics on Identification of Driver Genes Using Machine Learning Algorithms.
Li F; Chu X; Dai L; Wang J; Liu J; Shang J
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627101
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
[TBL] [Abstract][Full Text] [Related]
12. Why Are Some Driver Mutations Rare?
Nussinov R; Tsai CJ; Jang H
Trends Pharmacol Sci; 2019 Dec; 40(12):919-929. PubMed ID: 31699406
[TBL] [Abstract][Full Text] [Related]
13. MECoRank: cancer driver genes discovery simultaneously evaluating the impact of SNVs and differential expression on transcriptional networks.
Hui Y; Wei PJ; Xia J; Wang YT; Zheng CH
BMC Med Genomics; 2019 Dec; 12(Suppl 7):140. PubMed ID: 31888623
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations.
Taberlay PC; Achinger-Kawecka J; Lun AT; Buske FA; Sabir K; Gould CM; Zotenko E; Bert SA; Giles KA; Bauer DC; Smyth GK; Stirzaker C; O'Donoghue SI; Clark SJ
Genome Res; 2016 Jun; 26(6):719-31. PubMed ID: 27053337
[TBL] [Abstract][Full Text] [Related]
15. An integrated analysis of cancer genes in thyroid cancer.
Chai L; Li J; Lv Z
Oncol Rep; 2016 Feb; 35(2):962-70. PubMed ID: 26718127
[TBL] [Abstract][Full Text] [Related]
16. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Fleck JL; Pavel AB; Cassandras CG
BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
[TBL] [Abstract][Full Text] [Related]
17. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
Zhao M; Kim P; Mitra R; Zhao J; Zhao Z
Nucleic Acids Res; 2016 Jan; 44(D1):D1023-31. PubMed ID: 26590405
[TBL] [Abstract][Full Text] [Related]
18. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
Shu XS; Li L; Tao Q
Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
[TBL] [Abstract][Full Text] [Related]
19. Detection of driver pathways using mutated gene network in cancer.
Li F; Gao L; Ma X; Yang X
Mol Biosyst; 2016 Jun; 12(7):2135-41. PubMed ID: 27118146
[TBL] [Abstract][Full Text] [Related]
20. CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer.
Lever J; Zhao EY; Grewal J; Jones MR; Jones SJM
Nat Methods; 2019 Jun; 16(6):505-507. PubMed ID: 31110280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
